What are the key financial results for Johnson & Johnson in this quarter?

The provided text is a directory listing from the SEC filing and does not contain the actual financial statements or performance metrics. Therefore, specific financial results such as revenue, net income, or earnings per share for the quarter ending April 2, 1994, cannot be determined from this excerpt.

What business segments contributed most to Johnson & Johnson's performance?

This excerpt does not include the Management's Discussion and Analysis (MD&A) section or any segment reporting. To understand the performance of JNJ's different business segments (e.g., Pharmaceuticals, Medical Devices, Consumer Health), one would need to review the full 10-Q report.

Are there any significant risks or new developments mentioned in this filing?

The provided directory listing does not detail any specific risks, legal proceedings, or new business developments. These critical pieces of information are typically found in the full 10-Q filing, particularly within the MD&A and 'Risk Factors' sections, which are not available here.

JNJ 10-Q Quarterly Report Q2 FY1994 — Revenue, Net Income, EPS

Summary

This 10-Q filing from Johnson & Johnson (JNJ) for the period ending April 2, 1994, indicates the company's ongoing operations in the second quarter of its fiscal year. While the provided text is a directory listing and not the full financial report, it confirms the filing's existence and period. Investors would typically look for detailed financial statements, management's discussion and analysis (MD&A), and any material changes or risks disclosed in the full report. Without the actual financial data, a comprehensive analysis of JNJ's performance, profitability, and strategic direction for this quarter is not possible from this excerpt alone.

Key Highlights

1Filing confirmed: Johnson & Johnson (JNJ) filed a 10-Q Quarterly Report.
2Reporting period: The report covers the fiscal quarter ending April 2, 1994.
3Filing date: The report was filed with the SEC on July 11, 1994.
4Document type: This is a standard Quarterly Report (10-Q) filed under SEC regulations.
5Limited content provided: The excerpt is a directory listing and does not contain the actual financial statements or detailed business analysis.
6Investor focus: Investors would typically seek detailed financial metrics, revenue breakdowns, and management commentary on performance and outlook from the full filing.

JOHNSON & JOHNSON Quarterly Report for Q2 Ended Apr 3, 1994

Summary

Key Highlights

Frequently Asked Questions